Difficulty: Medium
Average Score: 65%
Practice
One of the following medications used in treatment of atopic dermatitis should be discontinued after failure to achieve good results within 4-6 weeks
Correct answer
C
Rationale
In the treatment of atopic dermatitis, it is important to understand the appropriate use of medications and their timelines for effectiveness. In this case, the correct answer is C) omalizumab. Omalizumab is a monoclonal antibody that targets IgE, which is involved in the allergic response seen in atopic dermatitis. If a patient fails to achieve good results within 4-6 weeks of starting omalizumab, it is recommended to discontinue this medication.
Regarding the other options:
A) Methotrexate and B) Azathioprine are immunosuppressant medications commonly used in the treatment of various dermatological conditions, but they are not typically first-line treatments for atopic dermatitis. These medications may take longer to show effectiveness, and discontinuing them after 4-6 weeks may not be appropriate.
D) Mycophenolate mofetil is another immunosuppressant used in dermatology for conditions such as lupus and psoriasis. Like methotrexate and azathioprine, mycophenolate mofetil may also require a longer timeframe to assess its efficacy in the treatment of atopic dermatitis.
In an educational context, understanding the appropriate use of medications for atopic dermatitis is crucial for pediatric nurses to provide safe and effective care to their patients. Knowing when to continue or discontinue specific medications based on treatment response timelines is essential in managing the condition and ensuring the best outcomes for the pediatric population.
Regarding the other options:
A) Methotrexate and B) Azathioprine are immunosuppressant medications commonly used in the treatment of various dermatological conditions, but they are not typically first-line treatments for atopic dermatitis. These medications may take longer to show effectiveness, and discontinuing them after 4-6 weeks may not be appropriate.
D) Mycophenolate mofetil is another immunosuppressant used in dermatology for conditions such as lupus and psoriasis. Like methotrexate and azathioprine, mycophenolate mofetil may also require a longer timeframe to assess its efficacy in the treatment of atopic dermatitis.
In an educational context, understanding the appropriate use of medications for atopic dermatitis is crucial for pediatric nurses to provide safe and effective care to their patients. Knowing when to continue or discontinue specific medications based on treatment response timelines is essential in managing the condition and ensuring the best outcomes for the pediatric population.